Tredje AP-fonden’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.6M | Buy |
412,667
+16,603
| +4% | +$902K | 0.08% | 257 |
|
|
2026
Q1 | $24.9M | Sell |
396,064
-750,825
| -65% | -$60.1M | 0.14% | 139 |
|
|
2025
Q4 | $109M | Buy |
1,146,889
+76,201
| +7% | +$7.47M | 0.82% | 26 |
|
|
2025
Q3 | $105M | Buy |
1,070,688
+210,000
| +24% | +$21.7M | 0.84% | 25 |
|
|
2025
Q2 | $92.4M | Buy |
860,688
+143,696
| +20% | +$14.5M | 0.74% | 35 |
|
|
2025
Q1 | $72.3M | Sell |
716,992
-72,819
| -9% | -$7.33M | 0.68% | 39 |
|
|
2024
Q4 | $70.5M | Sell |
789,811
-6,672
| -0.8% | -$587K | 0.63% | 37 |
|
|
2024
Q3 | $66.7M | Sell |
796,483
-220,000
| -22% | -$17.3M | 0.6% | 41 |
|
|
2024
Q2 | $78.3M | Sell |
1,016,483
-164,044
| -14% | -$12M | 0.76% | 31 |
|
|
2024
Q1 | $80.9M | Buy |
1,180,527
+36,000
| +3% | +$2.31M | 0.84% | 28 |
|
|
2023
Q4 | $66.2M | Buy |
1,144,527
+38,510
| +3% | +$2.06M | 0.83% | 27 |
|
|
2023
Q3 | $58.4M | Buy |
1,106,017
+9,710
| +0.9% | +$509K | 0.86% | 24 |
|
|
2023
Q2 | $59.3M | Sell |
1,096,307
-33,160
| -3% | -$1.73M | 0.84% | 25 |
|
|
2023
Q1 | $56.5M | Buy |
1,129,467
+47,607
| +4% | +$2.24M | 0.88% | 22 |
|
|
2022
Q4 | $50.1M | Buy |
1,081,860
+535,404
| +98% | +$23.2M | 0.85% | 22 |
|
|
2022
Q3 | $21.2M | Buy |
546,456
+274,714
| +101% | +$11M | 0.44% | 57 |
|
|
2022
Q2 | $10.1M | Hold |
271,742
| – | – | 0.25% | 90 |
|
|
2022
Q1 | $12M | Buy |
271,742
+15,000
| +6% | +$650K | 0.24% | 89 |
|
|
2021
Q4 | $10.9M | Buy |
256,742
+37,153
| +17% | +$1.56M | 0.21% | 102 |
|
|
2021
Q3 | $9.53M | Buy |
219,589
+20,000
| +10% | +$885K | 0.2% | 103 |
|
|
2021
Q2 | $8.53M | Hold |
199,589
| – | – | 0.17% | 93 |
|
|
2021
Q1 | $7.71M | Sell |
199,589
-34,000
| -15% | -$1.29M | 0.18% | 101 |
|
|
2020
Q4 | $8.4M | Buy |
233,589
+132,000
| +130% | +$4.76M | 0.22% | 90 |
|
|
2020
Q3 | $3.88M | Hold |
101,589
| – | – | 0.13% | 117 |
|
|
2020
Q2 | $3.57M | Hold |
101,589
| – | – | 0.15% | 112 |
|
|
2020
Q1 | $3.31M | Buy |
101,589
+16,732
| +20% | +$654K | 0.17% | 109 |
|
|
2019
Q4 | $3.84M | Sell |
84,857
-13,294
| -14% | -$556K | 0.19% | 130 |
|
|
2019
Q3 | $3.99M | Buy |
98,151
+1,200
| +1% | +$50.8K | 0.19% | 140 |
|
|
2019
Q2 | $4.17M | Hold |
96,951
| – | – | 0.2% | 121 |
|
|
2019
Q1 | $3.72M | Buy |
96,951
+10,265
| +12% | +$392K | 0.19% | 134 |
|
|
2018
Q4 | $3.06M | Buy |
86,686
+2,059
| +2% | +$74.7K | 0.19% | 134 |
|
|
2018
Q3 | $3.26M | Hold |
84,627
| – | – | 0.16% | 159 |
|
|
2018
Q2 | $2.77M | Sell |
84,627
-52,363
| -38% | -$1.58M | 0.1% | 251 |
|
|
2018
Q1 | $3.74M | Sell |
136,990
-8,156
| -6% | -$222K | 0.13% | 193 |
|
|
2017
Q4 | $3.6M | Buy |
145,146
+6,650
| +5% | +$183K | 0.12% | 202 |
|
|
2017
Q3 | $4.04M | Sell |
138,496
-14,090
| -9% | -$389K | 0.14% | 185 |
|
|
2017
Q2 | $4.23M | Sell |
152,586
-15,510
| -9% | -$412K | 0.16% | 173 |
|
|
2017
Q1 | $4.18M | Buy |
168,096
+13,824
| +9% | +$336K | 0.16% | 175 |
|
|
2016
Q4 | $3.34M | Buy |
154,272
+4,996
| +3% | +$109K | 0.14% | 199 |
|
|
2016
Q3 | $3.55M | Buy |
149,276
+14,626
| +11% | +$349K | 0.16% | 169 |
|
|
2016
Q2 | $3.15M | Buy |
134,650
+10,947
| +9% | +$237K | 0.14% | 165 |
|
|
2016
Q1 | $2.73M | Buy |
123,703
+37,682
| +44% | +$662K | 0.12% | 166 |
|
|
2015
Q4 | $1.59M | Buy |
86,021
+1,138
| +1% | +$20.4K | 0.1% | 180 |
|
|
2015
Q3 | $1.39M | Sell |
84,883
-9,501
| -10% | -$162K | 0.14% | 185 |
|
|
2015
Q2 | $1.67M | Buy |
+94,384
| New | +$1.69M | 0.13% | 186 |
|
Other funds holding BSX
Tredje AP-fonden's BSX Position: Q2 2026 in Review
Tredje AP-fonden increased its Boston Scientific (BSX) stake by 4.2% in Q2 2026, buying an estimated $902K and bringing the position to 412,667 shares worth $17.6M. The position accounts for 0.08% of the portfolio, ranked #257.
Tredje AP-fonden first reported a position in BSX in Q2 2015 and has held it in 45 quarters since. The position peaked at $109M in Q4 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Tredje AP-fonden held 412,667 shares of Boston Scientific worth $17.6M as of Q2 2026.
- Tredje AP-fonden bought 16,603 Boston Scientific shares in Q2 2026, an estimated $902K.
- Boston Scientific made up 0.08% of Tredje AP-fonden's portfolio in Q2 2026, its #257 holding.
- Tredje AP-fonden first reported a position in Boston Scientific in Q2 2015 and has held it in 45 quarters since.
- Tredje AP-fonden's Boston Scientific position peaked at $109M in Q4 2025.
- 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.